Background: Immigrants to developed countries are a major source of TB. Therefore amongst strategies adopted for TB control in developed countries include; 1) Screening immigrants at ports of entry referred to as "Port of Arrival Screening" (PoA) and 2) Passive screening (PS) for TB which means screening immigrants through general practices, hospitals, chest-clinics and emergency departments. Evidence of the effectiveness and cost effectiveness of these strategies is not consistent.
Background Historically, human migration had had a major impact on the spread of infectious diseases such as TB 1. Early nineteenth century, it was estimated that 25% of deaths in Western Europe were attributable to TB 2. Through travel TB spread to different parts of the world resulting in major epidemics in parts of sub-Saharan and central Africa, South-East Asia and the Americas 2. Following improvements in housing, nutrition and discoveries in antibiotics in the 1950s, incidence of TB fell in Western Europe and North America 1. However incidence continued to rise in resource-limited-settings3. In the face of globalisation with western economies booming, availability of cheap travel, political instability, man-made and natural disasters in less developed countries compounded by economic hardship, economic migration to the industrialised world has increased tremendously 4, majority of who come from high TB endemic-regions 5. Accordingly research evidence supports that migrants from TB endemic-countries con- tinue to have relatively high rates of latent TB for years after arrival in low TB prevalence countries 6,7. However a study of the transmission rates of mycobacterium (M) TB amongst different populations in Norway 8 to determine the genetic diversity of the population of M. TB isolates in TB patients and the degree of clustering of M. TB detected relatively little TB transmission from foreign-born residents to the general population. But there is consistent evidence that incidence of TB is higher amongst foreign-born ethnic-minority populations than native born-populations in the west; United States (US) 9, United Kingdom (UK) 10, Canada 11 and Switzerland 12. It was against this background in the late 20th century, some industrialised countries instituted port of entry TB screening for immigrants from high TB incidence regions; UK5,16,27, US15,18 and Canada11. However evidence of the effectiveness and cost effectiveness of new entrants' TB screening is inconsistent. It had been shown to be; effective 13,14,15, both effective and cost effective 16 but some researchers suggested no evidence of effectiveness 17,18,19 implying inconsistent public health research evidence for compulsory TB screening of new immigrants. Thus, this review reviewed the effectiveness and cost effectiveness of new entrants' TB screening schemes for immigrants from TB endemic regions to low TB prevalent countries. Epidemiology It has been estimated that of the one third of the world's population infected with TB, 8 million developed active TB with 5 000 deaths each day; 1.5 million occurred in Sub-Saharan Africa, 3 million in South-East Asia and over a quarter of a million in Eastern Europe 20. England like many industrialised countries where new entrants screening for TB is being practised on arrival, risk of TB is significantly higher in ethnic-minority groups; the crude incidence of active TB in native-born population in 1998 was 4.4/100 000 compared with 121-210/100 000 in ethnic-minorities 21. Similar evidence was supported in California 22 and Montreal 23. In England trends showed that TB rates peaked in early twentieth century with incidence of 300/100 000 per year which declined to 10/100 000 in 1987. The rates then fluctuated until 2007 with 14/100 000 population. However this represented a small increase of 0.7% compared with 2006 24. Current Service Provision (UK) In the UK new entrants TB screening guidelines were adapted from the national recommendations 5 by the government's independent health watchdog (NICE). Figure 1 shows a typical pathway for the screening of new entrants. On arrival new entrants from regions with TB prevalence of >/= 40/100 000 are screened verbally using a simple questionnaire. If no evidence of TB was found and the person has BCG scar, no action is taken. All new entrants under 35 years and those without BCG scar are subjected to TST test. If the test is negative (grades 0 or 1) they are offered BCG vaccination. If the test is positive (grades 2 or above) with/without signs and symptoms they are given anti-TB treatment/ chemoprophylaxis respectively. However if the test is less reliable, they should be considered for interferongamma immunological testing if available. On the other hand if the test is not conclusive, the person is referred for further investigations using chest x-ray/culture. If the result is consistent with active TB they are put on anti-TB treatment. Description of Interventions Any TB screening schemes instituted at PoA for new entrants from TB endemic-regions intending to stay in low TB prevalent country for at least six-months. The review aims to look at efficiency of the different schemes from host country's government perspective. Therefore any studies that investigated the effectiveness of screening subjects in their own countries were excluded because costs of such screening schemes are borne by subjects or their governments. -TB journals and websites eg. International union against TB (IUATB), Thorax, World health organisation (WHO) and internet searches using Google search engines.
Methodology for the Identification of Effectiveness
-Reference lists of studies thought to be relevant to the review were scanned for any additional studies. -Experts in new immigrants' screening were contacted for relevant information and knowledge of unpublished work on the subject. Study Inclusion/Exclusion Criteria Every retrieved citation was checked against a predetermined inclusion/exclusion criteria form (available on request). One reviewer (AS) checked the title and abstract of every article, which were independently verified by the second reviewer (MA). Any disagreement was discussed and consensus was achieved. The following shows the population, intervention, comparator and outcomes (PICO) of included studies; Population: Immigrants from TB endemic-regions with TB prevalence of >/= 40/100 000 population as recommended by British Thoracic Society 5.
Intervention: (See description of intervention). Studies were excluded if they had an inappropriate/no comparator arm in the study. Comparator: PS of immigrants' populations from TB endemic-regions through general practitioners and other modes of routine practice. It was considered for patients who had sought medical consultation either due to signs/symptoms of TB irrespective of prior screening history or for some other condition during which TB was accidentally diagnosed. Outcome Measures of Interest: -BCG vaccinations and chemoprophylaxis treatment prior and after screening respectively -Number of latent and active TB cases detected -Treatment outcomes of active TB; cured, treatment complete, died, failed, defaulted and transferred out defined according to WHO guideline 25. Study Design: For inclusion, studies must be of the following designs; -Cluster randomised trial -Prospective cohort studies and -Retrospective cohort studies Quality Assessment Two reviewers (AS and MA) independently quality assessed the included studies using the quality assessment methodological checklist for cohort studies 26, in order to minimise bias and errors in the conduct and analysis of primary studies. The criteria used to decide whether a study was of very good quality, good quality or poor is given below; 1.
If the study met all important characteristic quality attributes : very good 2.
If the study inadequately reported one or more of the quality attributes : good 3.
If the study did not met one or more quality attributes : poor NB: See study quality for the quality attributes Any disagreement was discussed and consensus achieved. A detail quality assessment methodological checklist is available on request. Data Extraction Using a predetermined data extraction form that was piloted on a sample of studies, one reviewer (AS) extracted the data presented in tabular forms (table 1 and  2 ).This allowed comparison between different studies in the evaluation of the effectiveness of the interventions in the studies. Extracted data was independently verified by MA. Any disagreement was discussed and consensus achieved.
Results of Included Effectiveness Studies Figure 2 -QUORUM FLOWCHART SHOWING STUDY SELECTION PROCESS OF PRIMARY EFFEC-TIVENESS STUDIES
Number of Studies Identified: 1443 citations were identified from the initial electronic searches. Of these 74 studies were retrieved for evaluation against the review's inclusion/exclusion criteria. 70 studies were excluded. Four retrospective cohort studies were included shown in figure 2. There were no cluster-randomised or prospective cohort studies. This may be reasonable given the risk and practical challenges of random allocation of people at high risk of TB to a non-intervention on entry. The studies have common objective, applied the same inclusion/exclusion criteria but reported different outcome measures.
Study Quality
Qualities of the studies were unanimously agreed as poor by the two reviewers, given the following reasons; • They were of design which is lower in the evidence-based hierarchy for effectiveness studies • Only Ormerod study reported total number of study population and effect size in the comparator group • There were high rates of non-respondents in the studies; Bothamley et al and Ormerod • Only Monney et al considered the validity and reliability of the assessment tools used • Ormerod and Verver et al did not report total number of study participants • All failed to report the relative risk which would have been helpful in assessing the risk of TB in the groups with significant heterogeneities. Studies' Characteristics Four studies met the inclusion criteria that were all retrospective cohort studies. The details of these studies and populations are provided in Of the four studies, Bothamley et al that assessed attendance for screening invitation showed active PoA had a smaller proportion of attendance for screening upon invitation compared with passive screening. Although a good proportion of PoA received TST, it was lower than that of passive screening. In terms of failure to attend reading of the TST, active PoA had the highest percentage shown in table 2. There were no significant tests for these differences. However in the group of homeless that comprised of both recent immigrants and local residents, attendance for reading of the TST was lower in the recent immigrants which was statistically significant; 26.2% and 45.6% respectively (chisquared = 10.1 with p< 0.01). No significance test reported P-value < 0.001 The duration of symptoms complaints at diagnosis in the active PoA and PS in Verver et al were; 4.2 weeks and 10.5 weeks respectively (p-value< 0.001). The active PoA screening reduced the total infectious period by 34% compared to 30% by PS. New entrants screened at PoA were 80% less likely to be hospitalised, OR = 0.2 (95% CI 0.1 -0.2). Heterogeneity between Results of Included Studies A detail analysis of the data proved that quantitative meta-analysis was not appropriate. The reasons include; -Inconsistent use of TB screening tools resulting in methodological and clinical heterogeneities; use of different screening questionnaire tools, targeting of high risk groups -Varying lengths of study periods resulting in either improvement or deterioration of TB programmes conditions either in the host country or applicant's -Use of different effect sizes and missing data.
Methods for Economic Analysis
The search for cost studies for this systematic review was based on a predefined study selection form available on request with search strategies and study selection process.
Results for Economic Analysis: One economic evaluation study was found. This was an embedded cost effectiveness analysis in one of the included effectiveness studies (Bothamley et al, 2002) .
Critique of Economic Study: The objective of the study was to assess the yield of screening in 3 screening schemes; active PoA screening, screening in GP and screening of a group of homeless. The perspective was not clearly stated. However it can be assumed that a national healthcare payer perspective was adapted because the government is the provider of all the alternatives and seems to have been conducted against the background that active PoA screening scheme has a poor yield and has been considered not effective 27. The study examined both costs and effects. The effects examined were; the cost per person screened per case and the cost per person screened per case of TB prevented and the cost effectiveness was determined as savings or benefits gained in one scheme compared with the other alternatives. However a threshold for effectiveness was not determined. Taking a National Health Service perspective, the analysis considered enough of the costs and consequences of TB screening including further investigations (table of the costs available on request). However capital/overhead and clerical costs were not available for GP. Indirect costs; transportation, TST reading, intangible and non-attendance were not included. The costs were measured in pound-sterling and to aid comparison of cost of the different schemes at different locations, authors chose an index of cost/person screened per case of TB prevented which allowed them to combine the outcomes of interest; BCG vaccination, prevention, treatment and diagnosis of TB. Incidence of TB was left in its natural unit which was appropriate to do.
No discounting despite the benefits of TB prevention could go beyond one year. Although the study showed GP screening was most cost effective (table 6) , sensitivity analysis to investigate the effect of identifying a case of TB showed that the benefit of screening was highly sensitive to the number of cases of TB identified and case holding during treatment. However authors did not calculate any incremental cost effectiveness ratio.
Discussion
The objective of this review was to assess the efficiency of active PoA TB screening for new entrants compared with PS. Four poor quality retrospective cohort-studies met the review's inclusion criteria. In terms of some outcome measures of interest; BCG and chemoprophylaxis interventions and treatment outcomes were not consistently reported. However all studies reported these outcomes; number of latent and active cases of TB.
PoA screening had the highest proportion of invitees for TB screening and easily identified at risk groups due to their exposure status and offered them chemoprophylaxis and BCG. However they had lower proportion of respondents and attendance to screening test. In terms of detections of latent and active TB cases, three out of the four studies showed that proportions of both cases have been consistently higher in PS groups. However proportions of latent and active TB cases detected by screening were higher in active PoA and PS groups of two studies; Verver et al and Bothamley et al respectively. Treatment outcomes were reported by two studies; these outcomes were available for 72% and 75% of cases that received treatment in active and passive screening groups respectively in Monney et al whilst treatment outcomes were available for 100% of notifications in Verver et al. Active PoA detected TB earlier when it was drug-sensitive with higher cure rates, however higher proportions of treatment completion and mortalities were in passive screening groups. These could be due to the long period of treatment during which immigrants change addresses frequently until they find a settled home and passive screening might had detected more severe cases not drug-sensitive. Assessment of outcomes of further investigations was not assessed in primary studies. However it was shown to be higher in the PoA. Given that in some countries qualification for a residence/work permit is linked to full assessment of immigrants TB status (Monney et al and Verver et al). This could be an encouragement for immigrants to comply with further investigations. In terms of signs and symptoms complaints, duration of symptoms complaints was statistically significantly lower in active PoA screening groups. Subsequently this correlates with statistically significantly fewer numbers of hospitalisations in the active PoA. One economic evaluation study was found, a cost effectiveness analysis of new entrants TB screening (Bothamley et al). The study showed that PS in general practice was most cost effective as the cost for screening immigrants in general practice, homeless and at PoA were; £1.26, £13.17 and £96.36 respectively and the cost per person screened per case of TB prevented were; £6.32, £23.00 and £10.00 respectively.
Study limitations
All studies included in the review were retrospective cohort studies which have inherited fundamental limitations such as recall and selection biases that put them at low level in the evidence hierarchy of effectiveness studies. Thus the review highlights the need for robust study-design; cluster-randomised study/prospective cohort study in-order to assess the efficiency of screening new entrants from TB endemic regions. Ideally a cost effectiveness study of the alternatives conducted alongside a cluster-randomised trial would be appropriate as this could influence the relationship between cost and effectiveness outcome ratios.
Conclusion
This review showed some evidence that active PoA screening of new entrants is worth doing. PoA screening more easily identified cases at high risk of infection and offered them treatment/chemoprophylaxis. However PS detected significant proportion of both active and latent cases. Active PoA screening showed consistent clear benefit in reducing the period of infectiousness which is an opportunity to protect others from TB transmission with subsequent avoidance of hospital admissions with most relevance to TB control programmes in developed countries. However passive screening is marginally less costly both in screening an individual and preventing a case.
